Home > Boards > US Listed > Biotechs > Geron Corp. (GERN)

Hi BB

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jeffqdhsr Member Profile
 
Followed By 2
Posts 917
Boards Moderated 0
Alias Born 08/09/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 6:57:30 AM
Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes GlobeNewswire Inc. - 10/10/2019 5:30:00 PM
Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis GlobeNewswire Inc. - 9/30/2019 4:19:00 PM
Geron to Present at 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 4:18:00 PM
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 8/22/2019 4:18:00 PM
Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes GlobeNewswire Inc. - 8/8/2019 8:08:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 4:26:07 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/1/2019 4:09:05 PM
Geron Corporation Reports Second Quarter 2019 Financial Results and Recent Events GlobeNewswire Inc. - 8/1/2019 4:05:00 PM
Geron to Announce Second Quarter Financial Results on August 1, 2019 GlobeNewswire Inc. - 7/25/2019 8:00:00 AM
Geron Enhances Oncology Expertise to Advance Corporate Objectives GlobeNewswire Inc. - 7/18/2019 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 7:08:08 PM
Geron Appoints Vice President, Human Resources GlobeNewswire Inc. - 6/20/2019 4:27:00 PM
Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress GlobeNewswire Inc. - 6/17/2019 8:20:00 AM
Geron to Webcast KOL Event on June 25, 2019 GlobeNewswire Inc. - 6/10/2019 4:45:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:26:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:25:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:24:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:24:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:23:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:19:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 5:22:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 9:26:22 AM
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress GlobeNewswire Inc. - 5/16/2019 9:05:49 AM
Geron Provides Imetelstat Program Update GlobeNewswire Inc. - 5/16/2019 8:00:00 AM
jeffqdhsr   Wednesday, 04/10/19 03:09:29 PM
Re: big bambino post# 6732
Post # of 6805 
Hi BB

Hope all is well ! Will we see $3-$4 ? Poss

IMO if we do see , back to $6-$7 is also poss , based on what i have read J&J made a business decision poss the 500 Mil year market for primary indication was not enough $ for them ?

So what is the difference , The drug still preformed well and shows promise. Fingers crossed !!

JMHO


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist